Company / SG&A per Share
10x Genomics, Inc. SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.59
FY2025
5-year range
$2.37 / $2.98
FY2021-FY2025
Trend
-10.6%
vs FY2024
Sector context
#102 of 150
Health Care
What the data says
At $2.59, 10x Genomics, Inc.'s sg&a per share ranks #49 of 150 in the Health Care sector. SG&A per Share has fluctuated over the past 9 years, ranging from $2.10 in FY2020 to $8.99 in FY2019.
Based on SEC 10-K filings.
2.59 in FY2025 with a 5-year CAGR of +4.2%.
Improved from $2.98 to $2.59 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -0.8%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
#49 of 150 in Health CareTop 32% of 150This company $2.59 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 10.6% year-over-year.
- Ranks #102 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.59 | -10.6% |
| FY2024 | $2.89 | -3.0% |
| FY2023 | $2.98 | +12.4% |
| FY2022 | $2.65 | +11.7% |
| FY2021 | $2.37 | +12.9% |
| FY2020 | $2.10 | -76.6% |
| FY2019 | $8.99 | +36.9% |
| FY2018 | $6.57 | +62.8% |
| FY2017 | $4.03 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026